Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > Message from the Ceo
View:
Post by kenster on Mar 11, 2020 10:49am

Message from the Ceo

 
Dear Ken,

Welcome to Emerald Health Therapeutics!

As a Canadian-based health and wellness company, we are committed to creating new consumer experiences by harnessing the power of the endocannabinoid system and cannabinoids to develop and deliver consistent, well-differentiated products to medical and recreational consumers.

With an emphasis on cannabis production excellence and product innovation, Emerald has built a platform of distinct operating assets designed to uniquely serve the Canadian marketplace and international opportunities while maintaining a focus on financial growth and strength.
 
Our 42.6%-owned joint venture, Pure Sunfarms (PSF), continues to excel and recently reported third-quarter results with net sales of $24.0M, a 69% gross margin, a 73% EBITDA margin and an all-in production cost at $0.63 per gram based on increased production volume and lower seasonal costs.
 
With our premium Qubec and certified organic British Columbia operations now readying for significant production of distinct high-quality cannabis products, Emerald’s strategy to have multiple complementary operations is maturing and we are transitioning into an effectively- integrated commercial phase of Emerald-produced and branded products.

With key legislative and sector turning points in Canada and on a global scale, it is an exciting time to be part of this important and evolving industry. We believe Emerald is well-positioned to continue carving out a unique role in this transitioning space.
 
On behalf of the Emerald team, I would like to thank you for your interest in our company. We look forward to sharing our news and advancements with you in the months ahead.

Riaz Bandali 
President & Chief Executive Officer 
Comment by bobbybittman on Mar 11, 2020 12:09pm
lol that letter is classic, market bs is gonna have a hayday with this one.  
Comment by Sthlheadr on Mar 11, 2020 9:12pm
Emerald has focused on achieving key milestones to build a unique position in the legal cannabis industry in Canada. The first cornerstone of our strategy - our 42.6%-owned Pure Sunfarms (PSF) joint venture - has quickly become one of the most competitive producers of high-quality, affordably-priced cannabis in Canada, and is shipping into Ontario, British Columbia, and Alberta. Pure Sunfarms ...more  
Comment by MarketBS on Mar 11, 2020 9:57pm
The way things are going EMH might be the best bet? imagine, EMH curing corona virus!
Comment by PANDEMICWATCH on Mar 13, 2020 5:33pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities